Contact Us
Drug Search Results
More Filters [+]

PF-07209960

Alternative Names: pf-07209960, pf 07209960, pf07209960
Latest Update: 2023-10-13
Latest Update Note: Clinical Trial Update

Product Description

Pfizer is developing PF-07209960 as a treatment for Advanced or Metastatic Solid Tumors. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT04628780)

Mechanisms of Action: IL15 Activator

Novel Mechanism: Yes

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PF-07209960

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Transitional Cell Carcinoma|Ovarian Cancer|Head and Neck Cancer|Non-Small-Cell Lung Cancer|Squamous Cell Carcinoma|Colorectal Cancer|Renal Cell Carcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
C4011001

P1

Terminated

Head and Neck Cancer|Colorectal Cancer|Squamous Cell Carcinoma|Renal Cell Carcinoma|Transitional Cell Carcinoma|Non-Small-Cell Lung Cancer|Ovarian Cancer

2023-05-03

43%

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions